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ABSTRACT 26 
 27 
Objective To investigate whether foot and/or ankle symptoms increase the risk of developing (i) 28 
knee symptoms and (ii) symptomatic radiographic knee osteoarthritis (OA). 29 
Design 1020 Osteoarthritis Initiative participants who were at-risk of knee OA, but were without 30 
knee symptoms or radiographic knee OA, were investigated. Participants indicated the presence 31 
and laterality of foot/ankle symptoms at baseline. The main outcome was development of knee 32 
symptoms (pain, aching or stiffness in and around the knee on most days of the month for at least 33 
one month in the past year). A secondary outcome was development of symptomatic 34 
radiographic knee OA (symptoms plus Kellgren and Lawrence [KL] grade >2), over the 35 
subsequent four years. Associations between foot/ankle symptoms and study outcomes were 36 
assessed by logistic regression models. 37 
Results Foot/ankle symptoms in either or both feet significantly increased the odds of 38 
developing knee symptoms (adjusted odds ratio (OR) 1.55, 95% confidence interval (CI) 1.10 to 39 
2.19), and developing symptomatic radiographic knee OA (adjusted OR 3.28, 95% CI 1.69 to 40 
6.37). Based on laterality, contralateral foot/ankle symptoms were associated with developing 41 
both knee symptoms (adjusted OR 1.68, 95% CI 1.05 to 2.68) and symptomatic radiographic 42 
knee OA (adjusted OR 3.08, 95% CI 1.06 to 8.98), whilst bilateral foot/ankle symptoms were 43 
associated with developing symptomatic radiographic knee OA (adjusted OR 4.02, 95% CI 1.76 44 
to 9.17). 45 
Conclusion In individuals at-risk of knee OA, the presence of contralateral foot/ankle symptoms 46 
in particular increases risk of developing both knee symptoms and symptomatic radiographic 47 
knee OA.  48 
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INTRODUCTION 52 
 53 
Knee osteoarthritis (OA) is a leading cause of joint pain1 and disability2 in middle- and older-54 
aged individuals, and is one of the most commonly managed conditions in primary care3. Recent 55 
incidence rates suggest around 6% of people aged over 45 years develop knee symptoms each 56 
year, whilst 2% develop symptomatic radiographic knee OA4. Knee OA symptoms and 57 
radiographic change that worsen over time can lead to costly surgical intervention. Thus 58 
understanding risk factors associated with the onset of knee symptoms alone or in combination 59 
with structural change is a major research focus. 60 
 61 
Symptoms in the foot and/or ankle is a potential risk factor for knee pain and OA that has 62 
received limited attention to date. Like knee OA, foot/ankle symptoms are very common in 63 
middle- and older-aged adults. They affect approximately 24% of people aged over 45 years5, 64 
and account for a substantial number of primary care consultations in this population6. Foot pain 65 
is highly disabling, reduces quality of life7, adversely affects walking and other daily functional 66 
abilities7 and increases the risk of falls8. To date, the majority of studies investigating symptoms 67 
at the foot/ankle and knee have examined these problems in isolation. However, isolated joint 68 
pain is rare9, and concurrent symptoms at the foot/ankle and knee is the most common multi-69 
joint presentation10, occurring far greater than expected by chance alone. In a recent cross-70 
sectional study using data from the Osteoarthritis Initiative (OAI), we found that people with 71 
both symptomatic radiographic knee OA and foot/ankle symptoms reported significantly worse 72 
general and knee OA specific health outcomes, and poorer physical function, than those with 73 
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knee OA but without foot/ankle symptoms11. Despite the strong association between problems at 74 
these two sites, their temporal sequence has not yet been evaluated.  75 
 76 
Investigating foot/ankle symptoms as a candidate risk factor for knee OA is attractive as it is 77 
simple to assess, and there is some evidence of potential modifiability using simple low-cost 78 
interventions such as off-the-shelf footwear12. Furthermore, there are a number of plausible 79 
biological mechanisms linking foot/ankle symptoms to knee OA development. For example, 80 
there may be shared biomechanical risk factors for the two problems, such as a pronated foot 81 
type13 or inappropriate footwear14. Alternatively, people with foot/ankle symptoms may walk 82 
differently to offload their painful foot15-17, altering knee function and increasing the risk of knee 83 
OA development. Finally, symptoms at these two sites may represent a widespread pain 84 
phenotype or an oligo- or polyarticular form of OA18. 85 
 86 
The primary aim of this study was to use longitudinal data from the OAI to examine whether 87 
foot/ankle symptoms predict the development of knee symptoms over four years in people 88 
without knee symptoms or radiographic knee OA, but at-risk of knee OA, at baseline. A 89 
secondary aim was to examine whether foot/ankle symptoms also predict the development of 90 
symptomatic radiographic knee OA over four years. It was hypothesized that foot/ankle 91 
symptoms would increase the odds of developing knee symptoms and symptomatic radiographic 92 
knee OA in people at risk of knee OA. 93 
 94 
METHODS 95 
 96 
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Study population 97 
 98 
The OAI is an ongoing prospective multicentre cohort study designed to evaluate and identify 99 
biomarkers for the onset and/or progression of knee OA in people aged between 45-79 years. 100 
The study enrolled 4796 men and women from four sites in the United States, including 101 
Baltimore, Maryland; Columbus, Ohio; Pittsburgh, Pennsylvania; and Pawtucket, Rhode Island. 102 
All protocols and procedures were approved by the institutional review board at each site19 and 103 
all participants provided informed consent. Details regarding general exclusion criteria and the 104 
wider study protocols are available online for public access (http://www.oai.ucsf.edu/). In the 105 
current study, we analyzed OAI participants who were at risk of knee OA, defined as the 106 
presence of two or more established characteristics including: overweight, identified using age- 107 
and sex-specific criteria; a history of knee injury causing walking difficulties; any knee surgery; 108 
an immediate family history of a total knee replacement for OA; Heberden’s nodes; repetitive 109 
knee bending during occupational or recreation activities; or aged between 70-79 years. From 110 
this subcohort, we only included people who did not have frequent knee symptoms (defined as 111 
pain, aching or stiffness in and around the knee on most days of the month for at least one month 112 
in the past year) or radiographic evidence of knee OA (Kellgren and Lawrence [KL] grade >2) in 113 
either knee at baseline. We excluded people (rather than knees) with these outcomes because the 114 
presence of symptomatic knee OA in one knee greatly increases the risk of developing 115 
contralateral knee OA which may confound results20-22. Demographic, clinical and radiographic 116 
characteristics of both knees for all participants were evaluated at baseline and at 12, 24, 36 and 117 
48-month follow-up visits.  118 
 119 
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Demographic characteristics and covariates 120 
 121 
Demographic data collected included age, sex and race (White, Black/African American or 122 
Asian/other non-white). Covariates included body mass index (BMI), , comorbidities and 123 
depression. As well as recording BMI values, we also classified participants as obese (>30 124 
kg/m2), overweight (≥25 and ≤30 kg/m2) or normal weight (<25 kg/m2). Comorbidities were 125 
assessed using the questionnaire version of the Charlson comorbidity index (CCI)23, and we 126 
dichotomized the cohort into those with ‘no comorbidities’ and those with ‘one or more 127 
comorbidities’. Depression was measured using the Centre for Epidemiological Studies 128 
Depression Scale (CES-D). Scores were summed and a score of ≥ 16 was used to indicate 129 
significant depressive symptoms24. 130 
 131 
 132 
Risk factor  133 
 134 
The primary risk factor was self-reported foot/ankle symptoms at baseline, defined as pain, 135 
aching or stiffness in the foot and/or ankle on more than half of the days during the past 30 days, 136 
consistent with definitions used in previous studies5, 10. In addition to classifying participants 137 
based on the presence or absence of symptoms in either foot/ankle, we further stratified 138 
foot/ankle symptoms as ipsilateral, contralateral or bilateral relative to each knee.  139 
 140 
Incidence outcomes 141 
 142 
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Knee symptoms  143 
 144 
Participants were asked about the presence of knee symptoms at baseline, and at the 12, 24, 36 145 
and 48 month follow-up visits for each knee. Incident knee symptoms was defined as 146 
development of pain, aching or stiffness in and around the knee on most days of the month for at 147 
least one month in the previous year, reported at any of the follow up visits, consistent with the 148 
OAI definition and based on American College of Rheumatology criteria for clinical knee OA25.  149 
 150 
Symptomatic radiographic knee osteoarthritis 151 
 152 
Weightbearing fixed-flexion posteroanterior radiographs of both knees were taken at baseline 153 
and at the 12, 24, 36 and 48 month follow-up visits. Radiographs were evaluated using the KL 154 
grading system (grades range 0-4) by two central OAI senior musculoskeletal experts blinded to 155 
all other participant data and to each other’s readings. Incident symptomatic radiographic knee 156 
OA was defined as knee symptoms (as per definition above) and the presence of KL grade >2 157 
based on the central OAI reading, at any of the follow up visits.  158 
 159 
Statistical analysis  160 
 161 
Baseline characteristics of participants with and without foot/ankle symptoms were summarised 162 
as number (%) for categorical variables and as mean (SD) or median (interquartile range) for 163 
continuous variables, as appropriate. Groups were compared using χ-squared tests, analysis of 164 
variance, Wilcoxon rank-sum or Kruskal-Wallis rank tests respectively. 165 
 166 
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To investigate the primary aim (development of knee symptoms), we analysed the association 167 
between any foot/ankle symptoms (i.e. symptoms in either or both feet/ankle) at baseline and the 168 
development of knee symptoms at any point within the four year follow-up period. For both 169 
aims, analyses were knee-specific (i.e. conducted at the knee level rather than at the participant 170 
level). Since most participants contributed two knees (8 participants with missing data 171 
contributed one knee only for the primary aim, and 3 participants with missing data contributed 172 
one knee only for the secondary aim), logistic regression models were fitted using generalized 173 
estimating equations to account for the correlation between left and right knees within 174 
participants. Two models were fitted, adjusting for sets of baseline covariates determined a 175 
priori. In the first model, only baseline foot/ankle symptoms were included to obtain unadjusted 176 
associations between baseline foot/ankle symptoms and the development of outcomes. The 177 
second model also included age, sex, race, BMI, Charlson Comorbidity index (dichotomised) 178 
and depression to adjust for variables known to be associated with both foot pain 26 and knee OA 179 
27
.  180 
 181 
In addition to considering whether any foot/ankle symptoms were associated with the outcome 182 
(i.e. at the participant level), we also investigated the association with ipsilateral, contralateral or 183 
bilateral foot/ankle symptoms (i.e. at the limb level) to see if the association differed by 184 
laterality.  Logistic regression models were again fitted using generalized estimating equations to 185 
adjust for clustering of knees within participants. Covariates were adjusted for in the same way 186 
as in the primary analysis. Similar analyses were conducted to address the secondary aim (the 187 
development of symptomatic radiographic knee OA), and the set of baseline variables was 188 
adjusted as per for the primary aim.  189 
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 190 
To assess the potential influence of confounders (both measured and unmeasured by the OAI) 191 
that were not accounted for in our analyses, we performed sensitivity analyses. More 192 
specifically, a causal inference-based approach adapted from Kasza et al28 was used. This 193 
approach varies a sensitivity parameter that quantifies the differences between participants with 194 
and without foot/ankle symptoms, had those without foot/ankle symptoms instead had 195 
symptoms. The sensitivity parameter compares the outcomes between two groups with the same 196 
exposure (where the exposure is hypothetical in those without foot/ankle symptoms), but with 197 
the possibility of differences that were unaccounted for in our analyses leading to differences in 198 
the development of knee symptoms and/or symptomatic radiographic knee OA. Values of the 199 
sensitivity parameter greater than 1 suggest that unaccounted confounders in those participants 200 
who actually had foot/ankle symptoms, such as widespread pain or generalised OA, contributed 201 
to the greater likelihood of those participants developing the outcome. Values of the sensitivity 202 
parameter equal to 1 suggest that there is no impact of unaccounted-for confounding on the 203 
results. Statistical significance was ascribed at p-value ≤ 0.05. Stata v12 (Stata Corporation, 204 
College Station, TX, USA) was used for all analyses. 205 
 206 
RESULTS 207 
 208 
Sample characteristics 209 
 210 
This study used OAI participants who did not have symptomatic radiographic knee OA 211 
(n=3306). Patients with knee symptoms (as defined previously) or radiographic knee OA (KL>2) 212 
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in one or both knees at baseline were excluded (n=2286) (Figure 1). Demographic data are 213 
presented in Table 1. Of the 1020 participants at baseline, 13% (n=133) reported symptoms in at 214 
least one foot/ankle. Those with foot/ankle symptoms were more likely to be female (p=0.014), 215 
younger (p=0.029), Black/African American (p<0.001) and have a higher BMI (p=0.003) at 216 
baseline. There were no differences in baseline measures of worst KL grade, comorbidities, 217 
depressive symptoms, shoulder pain, Heberden’s nodes, or previous knee injury or surgery 218 
between those with and without foot/ankle symptoms.  219 
 220 
Insert Figure 1 near here 221 
 222 
Insert Table 1 near here 223 
 224 
Development of knee symptoms  225 
 226 
Table 2 shows the odds of developing knee symptoms according to the presence and laterality of 227 
foot/ankle symptoms. After excluding knees with missing data, there were 1990 knees from 999 228 
participants available for analysis. Baseline symptoms in any foot/ankle was associated with a 229 
significantly increased risk of developing knee symptoms in the subsequent four years (adjusted 230 
OR 1.55, 95% CI 1.10 to 2.19). Additional analyses of foot/ankle and knee symptom laterality 231 
showed that contralateral foot/ankle symptoms also increased the odds for developing knee 232 
symptoms (adjusted OR 1.68, 95% CI 1.05 to 2.68). 233 
 234 
Insert Table 2 near here 235 
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 236 
Development of symptomatic radiographic knee OA  237 
 238 
Table 3 shows the odds of developing symptomatic radiographic knee OA according to the 239 
presence and laterality of foot/ankle symptoms. After excluding knees with missing data, there 240 
were 1983 knees from 993 people available for analysis. Baseline symptoms in any foot/ankle 241 
was associated with a significantly increased risk of developing symptomatic radiographic knee 242 
OA at any time in the follow up period (adjusted OR 3.28, 95% CI 1.69 to 6.37). Subgroup 243 
analyses based on foot/ankle symptom laterality suggested bilateral foot/ankle symptoms had the 244 
highest odds for developing symptomatic radiographic knee OA (adjusted OR 4.02, 95% CI 1.76 245 
to 9.17), and that foot/ankle symptoms that were contralateral to the affected knee also increased 246 
the risk of this outcome (adjusted OR 3.08, 95% CI 1.60 to 8.98). 247 
 248 
Insert Table 3 near here 249 
 250 
Sensitivity analyses 251 
 252 
The results of our sensitivity analyses suggest that it is highly unlikely that any confounder not 253 
included in our analyses would have explained the observed association between foot/ankle 254 
symptoms and the development of knee symptoms and symptomatic radiographic knee OA. 255 
Specifically, the sensitivity analysis for developing knee symptoms (Figure 2) indicates that 256 
when the sensitivity parameter is about 1.3, the odds ratio reduces to 1. Hence, for the 257 
association to be entirely explained by unaccounted-for confounding, those with foot/ankle 258 
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symptoms would need to be 30% more likely to develop the outcome than those without 259 
symptoms would be had they also had foot/ankle symptoms. The sensitivity parameter required 260 
to explain the association between foot/ankle symptoms and symptomatic radiographic knee OA 261 
is even greater (Figure 3): those with foot/ankle symptoms need to be more than twice as likely 262 
to develop the outcome than those without symptoms would be had they also had foot/ankle 263 
symptoms. Figures 2 and 3 indicate as the value of the sensitivity parameter gets greater 264 
(corresponding to the greater tendency to develop the outcome among those with foot/ankle 265 
symptoms), the sensitivity parameter-adjusted OR is further reduced.  266 
 267 
Insert Figures 2 and 3 near here 268 
 269 
DISCUSSION 270 
 271 
This is the first study to investigate whether foot/ankle symptoms are a risk factor for the 272 
development of knee symptoms and symptomatic radiographic knee OA in people at-risk of the 273 
disease. Foot/ankle symptoms in either or both sides were found to increase the risk of 274 
developing knee symptoms over the subsequent four years, with contralateral foot/ankle 275 
symptoms the only side to show an association with knee symptom development in the laterality 276 
analysis. Foot/ankle symptoms in either or both sides were also found to increase the risk of 277 
developing symptomatic radiographic knee OA, with bilateral and contralateral foot/ankle 278 
symptoms both associated, however there were few cases who developed this outcome and 279 
confidence intervals were wide. These findings add to previous cross-sectional studies 280 
demonstrating strong associations between symptoms at the foot/ankle and knee10, 11, and they 281 
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provide the first longitudinal evidence that foot/ankle symptoms are a risk factor for the 282 
development of knee symptoms, and symptomatic radiographic knee OA.  283 
 284 
Few studies have investigated risk factors for the onset of knee symptoms. A large prospective 285 
cohort study previously identified previous knee injury as the strongest predictor of onset of 286 
future knee pain with similar odds ratios to ours (1.59 compared t0 1.60)29. Furthermore, 287 
although a number of other risk factors for the development of symptomatic radiographic knee 288 
OA have been previously reported, such as age and ethnicity, few are modifiable. Currently, the 289 
strongest known modifiable risk factors for developing knee OA are obesity and previous knee 290 
injury30. Our odds of around 3.3 for developing symptomatic radiographic knee OA are also 291 
comparable to these other potentially modifiable factors (pooled OR 2.6 for BMI and 3.9 for 292 
knee injury)30.  However, some caution should be used when interpreting the outcomes of our 293 
symptomatic radiographic model. Firstly, despite our large cohort with several years' follow-up 294 
and our use of knee-level data, few cases developed symptomatic radiographic knee OA. This 295 
reduces the precision of the odds ratio for this model, as seen by the wide confidence intervals. 296 
With so few cases, and adjustment for six covariates, there is also some risk of over-fitting our 297 
regression models. However, our number of events per variable in the model (including 298 
covariates) was within recommendations31. Finally, our four year follow up may be too short to 299 
appropriately evaluate symptomatic radiographic outcomes. However, the OAI only has biennial 300 
radiographic data available after four years, and we felt that it would overly complicate our 301 
outcome definition to have annual outcomes up to four years and biennial data thereafter. 302 
Notwithstanding these points, the results for all of our models were broadly consistent which 303 
suggests that it is likely that there is some association between foot/ankle symptoms and 304 
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symptomatic radiographic knee OA. The findings are also reasonably robust given our sensitivity 305 
analyses showed that it is unlikely that our conclusions would be changed had we adjusted for 306 
other confounders not included in our analyses.  307 
 308 
There are several plausible mechanisms by which foot pain could be linked to the subsequent 309 
onset of knee symptoms in people at-risk of knee OA. First, people with foot/ankle symptoms 310 
alter their walking pattern7 and these biomechanical changes may increase the risk of developing 311 
knee OA. To date, the effects of foot/ankle symptoms on biomechanics relevant to knee OA have 312 
not been explored, however our findings of an association between contralateral but not 313 
ipsilateral foot symptoms suggest people with foot/ankle symptoms may shift weight away from 314 
the painful foot and increase load on the contralateral knee. Second, it has been suggested that a 315 
more pronated or “flatter” foot, which is associated with many painful foot conditions32-34, may 316 
increase rotational stress on the tibiofemoral joint13, due in part to the tight coupling between 317 
movement at the rearfoot and tibia35. Over time, this abnormal stress may damage the load-318 
bearing tissues in the knee joint leading to pain and structural damage13. However, whilst some 319 
cross-sectional studies show increased foot pronation in people with knee OA36, and that a more 320 
pronated foot is associated with an increased prevalence of knee pain and medial tibiofemoral 321 
cartilage damage13, other research suggests increased pronation may instead be a compensatory 322 
mechanism designed to reduce knee load and pain37. Third, footwear may be a shared risk factor 323 
for both foot/ankle symptoms and knee OA. For example, inappropriate footwear is a risk factor 324 
for foot/ankle symptoms, and some types of footwear such as high heels may also alter knee 325 
biomechanics in a detrimental manner14, 38. Other researchers have suggested that pain in 326 
multiple joints in people with knee OA may reflect a more generalized (e.g. oligo- or 327 
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polyarticular) OA presentation39 or a widespread pain phenotype18, partly due to changes in 328 
central pain processing40, 41. These central changes may lead to a generalized hypersensitivity to 329 
pain and therefore a greater likelihood of developing pain at multiple sites such as the knee and 330 
foot. However this does not appear to be explanatory in our findings given our conclusions 331 
remained unchanged after we performed sensitivity analyses to account for unaccounted-for 332 
confounders.  333 
 334 
There is evidence that foot foot/ankle symptoms may be modifiable given studies have shown 335 
simple and relatively inexpensive conservative interventions are effective at treating common 336 
causes of foot foot/ankle symptoms. For example, off-the-shelf footwear was reported to 337 
improve general foot pain in older people12 and foot pain due to gout42, whilst foot orthoses have 338 
been shown to improve pain and function in people with plantar fasciitis43, pes cavus44 and 339 
rheumatoid arthritis45, amongst others. If the mechanism underpinning the association between 340 
foot/ankle symptoms and the development of knee symptoms is due to shifting weight to the 341 
contralateral limb to unload the painful foot/ankle, then simple analgesic interventions may also 342 
be helpful in reducing the need for this avoidance strategy. Further studies are now required to 343 
determine whether treating foot foot/ankle symptoms using conservative interventions also helps 344 
to reduce the incidence of knee pain and symptomatic radiographic knee OA in people at risk of 345 
the disease. 346 
 347 
There are some limitations to our study. Firstly, although we found a relationship between 348 
foot/ankle symptoms and the development of symptomatic and radiographic knee OA, it cannot 349 
be determined whether this is an independent relationship to structural or radiographic knee OA 350 
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as these participants are a subset of those who developed knee symptoms. The relationship 351 
between foot/ankle symptoms and the development of radiographic knee OA alone was not 352 
explored given that radiographic OA without symptoms is not clinically relevant. Second, 353 
participants were required to have reported knee symptoms at only one of the follow up visits 354 
similar to previous research46, thus it is possible our analyses included people whose knee 355 
symptoms were not sustained over time. We feel that this was appropriate given OAI data have 356 
shown knee pain profiles are stable over 6 years47. However, future studies may wish to examine 357 
whether foot/ankle symptoms are associated with more sustained knee pain. Third, we 358 
dichotomised BMI and the Charlson comorbidity index which can leave residual confounding48. 359 
However, we found no strong evidence of this when we re-ran the analyses using fractional 360 
polynomials to model the continuous scores for these covariates (see Table 1 in the 361 
supplementary analyses). It is also possible that our results were biased due to the exclusion of 362 
participants because of missing x-rays. However when we compared demographic characteristics 363 
and covariates between those with missing and non-missing x-rays, our results showed those 364 
with missing x-rays were more similar to OAI participants with KL>2 at baseline than to those 365 
with KL grade 0 and 1 (see Table 2 in the supplementary analyses). Since those with KL≥2 were 366 
excluded from the study, it is possible that the participants with missing data would have been 367 
excluded regardless. Thus the impact of missing data on our outcomes is likely to be minimal. 368 
Finally, we tested a cohort who was already at an increased risk of developing knee OA and thus 369 
our results should not be generalised to the wider population. Further research is needed to 370 
determine whether foot/ankle symptoms also increase the risk of developing knee symptoms in a 371 
population that does not possess other knee OA risk factors. 372 
 373 
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In conclusion, our study showed that people with foot/ankle symptoms were at an increased risk 374 
of developing knee OA symptoms and symptomatic radiographic knee OA compared to those 375 
without foot/ankle symptoms. These findings have important clinical and research implications. 376 
Although it is unclear whether foot/ankle symptoms directly causes knee symptoms and 377 
radiographic changes, or whether its presence is an indirect clinical marker for another variable, 378 
our results have identified a potentially modifiable risk factor for knee OA in people at-risk of 379 
the disease. Future studies should now determine whether addressing foot/ankle symptoms using 380 
conservative interventions reduces the incidence of knee pain and symptomatic radiographic 381 
knee OA. 382 
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FIGURE LEGENDS 557 
 558 
Figure 1. Participants from the Osteoarthritis Initiative included in analysis. 559 
Figure 2. Results of the sensitivity analysis for developing knee symptoms. 560 
Figure 3. Results of the sensitivity analysis for developing symptomatic radiographic knee OA. 561 
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TABLES 563 
Table 1. Baseline characteristics of Osteoarthritis Initiative participants without knee pain classified based on the presence and side of 564 
foot/ankle symptoms. One participant had missing foot/ankle symptom status at baseline. Values are N (%) unless otherwise indicated. 565 
Characteristic Missing (n) No foot/ankle symptoms (n=887) Any foot/ankle symptoms (n=133) P value† 
Mean (SD) age (years) 0 60.9 (9.1) 59.0 (9.3) 0.029 
Sex 0 
  
0.014 
 
Male 
 
387 (43.6) 43 (32.3) 
 
 
Female 
 
500 (56.4) 90 (67.7) 
 
Race: 0 
  
<0.001 
 Asian and other non-white 
 
14 (1.6) 10 (7.5) 
 
 White/Caucasian 
 
793 (89.4) 107 (80.5) 
 
 Black/African American 
 
80 (9.0) 16 (12.0) 
 
Median (IQR) BMI kg/m2 1 26.4 (23.7, 30.0) 27.7 (24.8, 32.0) 0.003 
BMI categories: 1 
  
0.018 
 
Normal  
(BMI <25 kg/m2)  
317 (35.7) 34 (25.6) 
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Overweight  
(BMI 25-30 kg/m2)  
347 (39.1) 52 (39.1) 
 
 
Obese  
(BMI >30 kg/m2)  
223 (25.1) 47 (35.3) 
 
Worst KL grade*  0 
  
0.937 
 0 
 
568 (64.0) 84 (63.2) 
 
 1 
 
319 (36.0) 49 (36.8) 
 
 2 
 
0 (0) 0 (0) 
 
 3 
 
0 (0) 0 (0) 
 
 4 
 
0 (0) 0 (0) 
 
Comorbidities: 0 
  
0.134 
 0 
 
692 (78.0) 96 (72.2) 
 
 >1 
 
195 (22.0) 37 (27.8) 
 
Depression 8   0.351 
 No  827 (93.7) 118 (91.5)  
 Yes  56 (6.3) 11 (8.5)  
 566 
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SD, standard deviation; IQR, interquartile range; BMI, body mass index; KL, Kellgren Lawrence. 567 
*
 Baseline values 568 
†
 P-values from chi-squared test for binary and categorical variables, Wilcoxon rank-sum or Kruskal-Wallis rank tests for variables 569 
presented as median (IQR), and analysis of variance tests for variables presented as mean (SD). 570 
  571 
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Table 2. Logistic regression analyses for the risk of developing knee symptoms during the four year follow up period. GEEs fit to 572 
account for the clustering of knees within participants. 50 knees from 29 participants were excluded due to missing data. 573 
 574 
Laterality of 
foot/ankle 
symptoms 
Total 
number of 
knees 
(participants) 
No knee 
symptoms 
N (%) 
Knee 
symptoms 
N (%) 
Risk for knee symptoms 
Unadjusted 
OR (95% CI) 
P value 
Adjusted† 
OR (95% CI) 
P value 
No symptoms (ref) 1742 (874) 1135 (89.7) 607 (83.8) 1  1  
Any side 248 (125) 131 (10.3) 117 (16.2) 1.63 (1.16 to 2.27) 0.004 1.55 (1.10 to 2.19) 0.012 
        
Ipsilateral 70 (70) 40 (3.2) 30 (4.1) 1.34 (0.83 to 2.17) 0.238 1.30 (0.80 to 2.12) 0.294 
Contralateral 72 (72) 37 (2.9) 35 (4.8) 1.77 (1.11 to 2.84) 0.017 1.68 (1.05 to 2.68) 0.030 
Bilateral 106 (53) 54 (4.3) 52 (7.2) 1.74 (1.06 to 2.86) 0.029 1.65 (0.98 to 2.78) 0.060 
 575 
OR, odds ratios; CI, confidence intervals. 576 
†
 Adjusted for age, sex, race, BMI, Charlson Comorbidity index (dichotomised) and depression. 577 
 578 
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Table 3. Logistic regression analyses for the risk of developing symptomatic and radiographic knee OA, during the four year follow 579 
up period. GEEs fit to account for the clustering of knees within participants. 57 knees from 30 participants were excluded due to 580 
missing data. 581 
 582 
Laterality of 
foot/ankle 
symptoms 
Total number 
of knees 
(participants) 
No symptomatic 
knee ROA 
N (%) 
Symptomatic 
Knee ROA 
N (%) 
Risk for symptomatic knee ROA 
Unadjusted 
OR (95% CI) 
P value 
Adjusted† 
OR (95% CI) 
P value 
No symptoms (ref) 1736 (869) 1707 (88.1) 29 (64.4) 1  1  
Any side 247 (124) 231 (11.9) 16 (35.6) 4.26 (2.23 to 8.12) <0.001 3.28 (1.69 to 6.37) 0.0004 
        
Ipsilateral 70 (70) 67 (3.5) 3 (6.7) 2.57 (0.76 to 8.74) 0.131 2.28 (0.70 to 7.37) 0.171 
Contralateral 71 (71) 67 (3.5) 4 (8.9) 4.35 (1.61 to 11.74) 0.004 3.08 (1.06 to 8.98) 0.039 
Bilateral 106 (53) 97 (5.0) 9 (20.0) 5.38 (2.50 to 11.55) <0.001 4.02 (1.76 to 9.17) 0.001 
 583 
OA, osteoarthritis; ROA, radiographic osteoarthritis; OR, odds ratios; CI, confidence intervals. 584 
†
 Adjusted for age, sex, race, BMI, Charlson Comorbidity index (dichotomised) and depression. 585 
 586 
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Osteoarthritis Initiative (OAI) 
participants at baseline (n=4796) 
OAI participants without symptomatic 
knee OA (n=3306 participants) 
Excluded: 
• Healthy control participants without 
risk factors for knee OA (n=122)  
• Participants with symptomatic 
radiographic knee OA (n=1368) 
 
Eligible sample = 1020 participants (2040 knees) 
 
Aim 1: Development of knee symptoms 
 
Aim 2: Development of symptomatic radiographic knee OA 
 
Excluded: 
• Participants who reported knee symptoms 
or had missing knee symptoms at baseline 
(or both) (n=1061 participants) 
• Participants with KL ≥ 2 or missing KL 
grade at baseline (n=1225) 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
 
